3,4-Dimethoxyphenylacetonitrile

We are 3,4-Dimethoxyphenylacetonitrile CAS:93-17-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   3,4-Dimethoxyphenylacetonitrile
CAS.NO:  93-17-4
Synonyms:
Benzeneacetonitrile, 3,4-dimethoxy-
2-(3,4-dimethoxyphenyl)acetonitrile

Molecular Formula:C10H11NO2
Molecular Weight: 177.20000

Physical and Chemical Properties:
Density: 1.082 g / cm3
Boiling point: 171-178 ° C10 mm Hg (lit.)
Melting point: 54-57 ° C (lit.)
Flash point:> 230 ° F
Refractive index: 1.511

Specification:
Appearance: White or off white crystaline powder
Purity:≥99%
Water:0.5% max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Verapamil Hydrochloride CAS:23313-68-0

3,4-Dimethoxyphenylacetonitrile


Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.D-serina metil éster hidrocloruro CAS:5874-57-7 The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.Ácido 3-boronobenzoico CAS:25487-66-5 The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.Ethyl 2-hydroxyethyl sulfide CAS:110-77-0 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.

Related Products
Product Name
4-Isopropylbenzeneboronic Acid View Details
N,N-Diethyl-3-oxobutyramide View Details
1-(1H-Indol-6-yl)ethanone View Details
4-Bromo-2,6-difluoroaniline manufacturer methyl 3-bromo-2-fluorobenzoate manufacturer 2,4-Dichloro-5-Isopropoxyaniline manufacturer (2S)-propane-1,2-diamine,dihydrochloride manufacturer [2-chloro-6-fluoro-4-(trifluoromethyl)phenyl]hydrazine manufacturer